---
title: "Tong Ren Tang Technologies Proposes Final 2025 Dividend and Outlines Tax Treatment"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/280790184.md"
description: "Tong Ren Tang Technologies Co. Ltd. has proposed a final ordinary cash dividend of RMB 0.18 per share for the financial year ending December 31, 2025, with payment set for August 11, 2026, pending shareholder approval. The company outlined tax treatments for H-share investors, including a 10% corporate income tax for non-resident enterprises and varying individual income tax rates. The latest analyst rating for the stock (HK:1666) is a Hold with a price target of HK$4.50. The company operates in the pharmaceutical sector and adheres to PRC tax regulations."
datetime: "2026-03-27T12:02:11.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/280790184.md)
  - [en](https://longbridge.com/en/news/280790184.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/280790184.md)
---

# Tong Ren Tang Technologies Proposes Final 2025 Dividend and Outlines Tax Treatment

### Claim 30% Off TipRanks Premium

-   Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
-   Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential

The latest announcement is out from Tong Ren Tang Technologies Co ( (HK:1666) ).

Tong Ren Tang Technologies Co. Ltd. has announced a proposed final ordinary cash dividend of RMB 0.18 per share for the financial year ended 31 December 2025, with payment scheduled for 11 August 2026, subject to shareholder approval. Key timetable details, including ex-dividend date, record date, and the default payout currency, will be announced later, and Computershare Hong Kong Investor Services will serve as the share registrar.

The company has detailed the withholding tax treatment that will apply to H-share investors based on their residency and investment channel, including a 10% corporate income tax for non-resident enterprise shareholders, a 10% individual income tax for most non-resident individuals, and a 20% individual income tax for investors accessing H shares via Shenzhen-Hong Kong Stock Connect. These tax arrangements clarify the net dividend investors can expect and underscore the company’s adherence to PRC tax regulations, while explicitly disclaiming responsibility for individual shareholders’ tax status or any disputes over withholding mechanisms.

The most recent analyst rating on (HK:1666) stock is a Hold with a HK$4.50 price target. To see the full list of analyst forecasts on Tong Ren Tang Technologies Co stock, see the HK:1666 Stock Forecast page.

**More about Tong Ren Tang Technologies Co**

Tong Ren Tang Technologies Co. Ltd. is a Hong Kong-listed company engaged in the manufacture and sale of pharmaceutical products, with its shares traded under stock code 01666. The company issues H shares to both resident and non-resident investors and is subject to Mainland Chinese tax rules on dividend distributions to different categories of shareholders.

**Average Trading Volume:** 1,146,049

**Technical Sentiment Signal:** Sell

**Current Market Cap:** HK$5.11B

For a thorough assessment of 1666 stock, go to TipRanks’ Stock Analysis page.

### Related Stocks

- [01666.HK](https://longbridge.com/en/quote/01666.HK.md)

## Related News & Research

- [USA Compression Partners Announces 2025 K-3 Tax Package Availability | USAC Stock News](https://longbridge.com/en/news/286620216.md)
- [Nuvo adds Avalara tax tools to B2B customer onboarding software](https://longbridge.com/en/news/286971059.md)
- [Wall Street’s new tax trade chases losses in a bull market: WSJ](https://longbridge.com/en/news/286680785.md)
- [Wall Street turns to year-round tax-loss harvesting surge](https://longbridge.com/en/news/286678461.md)
- [SC to hear tax department plea against Vedanta relief in TDS dispute](https://longbridge.com/en/news/286788354.md)